Recent Updates
Recently added Catalysts

Dapsone Formulation A

Phase 1

Acne Vulgaris | Small molecule | Dermatology |AbbVie Inc.|Last Updated: Apr 24, 2019

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment77
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01773122Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne VulgarisPHASE1 COMPLETED 77Jan 21, 2013May 5, 2013Apr 24, 20191 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Maximum Plasma Level (Cmax) of Dapsone
Day 28

Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended.

Secondary Endpoints
Maximum Plasma Level (Cmax) of Dapsone Metabolites
Day 28
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Dapsone Formulation AEXPERIMENTALDapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone Formulation BEXPERIMENTALDapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone Formulation CEXPERIMENTALDapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone 5% GelACTIVE_COMPARATORDapsone 5% gel (ACZONE®) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.
Interventions
NameTypeDescription
Dapsone Formulation ADRUGDapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone Formulation BDRUGDapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone Formulation CDRUGDapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.
Dapsone 5% GelDRUGDapsone 5% gel (ACZONE®) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.
Unlock Study Design Details
Eligibility Criteria
Age Range16 Years — 35 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Diagnosis of acne vulgaris * Willing to avoid excessive or prolonged exposure to ultraviolet light (e.g., sunlight, tanning beds) throughout the study * If male, the subject must agree to shave the facial treatment area and agree to maintain his routine shaving regimen for the...

Countries:United States
Unlock Eligibility Criteria